Wuhan, China — September 29, 2025 — Landing Med is proud to announce that our Founder and Chairwoman, Dr. Xiaorong Sun, has been named to The Pathologist Power List 2025, featured in this year’s “Leading Voices” edition.
This annual list honors individuals whose innovation, leadership, and advocacy are shaping the future of pathology and laboratory medicine. Dr. Sun’s inclusion reflects her significant contributions to advancing population-based cervical cytology screening and her commitment to expanding access to high-quality diagnostics worldwide, especially in underserved areas.
Under Dr. Sun’s leadership, Landing Med continues to transform China’s cervical cancer screening through innovative, scalable, and accessible AI solutions. Milestones include:
The world’s largest AI-powered cloud platforms for LBC cervical cytology screening, serving over 13 million women
Efficient quality control system to enhance accuracy, efficiency, and early detection of cervical cancer, supported by advanced cytology consumables that ensure sample integrity
Ongoing efforts to bridge healthcare gaps in underserved regions through practical and affordable digital pathology technologies, including cutting-edge digital slide scanners that enable rapid and accurate diagnosis
These advancements demonstrate Dr. Sun’s mission-driven focus on improving health outcomes for women globally, leveraging tools such as the histology slide scanner to complement cytology workflows.
The Pathologist Power List is determined through a “blind” review process, ensuring selections are made solely on impact and achievement. The 2025 Leading Voices edition spotlighted individuals who contribute fresh perspectives, drive meaningful reform, and elevate the visibility of pathology across disciplines.
Dr. Sun’s recognition acknowledges both her technical leadership and her role as a global advocate for equitable access to diagnostic care.
“Being named to The Pathologist Power List is a tremendous honor and a testament to the dedication of the entire Landing Med team. Our mission is to bring high-quality, AI cytology to those who need it most — especially in regions where medical resources are limited. This recognition encourages us to continue pushing the boundaries of innovation and expanding access to life-saving screening technologies.”
Learn more about Dr. Sun’s recognition and essay on The Pathologist:
https://thepathologist.com/power-list/2025/what-gaps-in-technologytrainingprocesses-concern-you-most-and-how-are-you-addressing-them-via-innovation/xiaorong-sun/
fr 
es 
CN
